Unknown

Dataset Information

0

A retrospective study of NENs and miR-224 promotes apoptosis of BON-1 cells by targeting PCSK9 inhibition.


ABSTRACT: Neuroendocrine neoplasms (NENs) represent relatively rare tumors. The lack of diagnostic, therapeutic method and prognostic factors makes them a challenge to us. We retrospectively reviewed the data of 205 NENs patients among which 157 cases were followed-up. Proprotein convertase subtilisin/kexin 9 (PCSK9), a regulator of low density lipoprotein cholesterol (LDL-C), was confirmed as a target gene of microRNA-224. We found an increased incidence of NENs from 2012 to 2015. Women were usually diagnosed at earlier stages than men (P < 0.05). Tumor grading was associated with primary tumor site, especially esophagus and cardia NENs all at G3 (P <0.001). Age, tumor grading and LDL-C levels were independent risk factors of digestive NENs. Low LDL-C level was significantly correlated with survival rate and median overall survival (OS, P < 0.05). MicroRNA-224 agomir and PCSK9 siRNA could promote apoptosis and suppress proliferation, invasion of BON-1 cells (P < 0.05), but increase the level of glucocorticoid (GC, P < 0.05). Taken together, age, tumor grading and LDL-C level are independent risk factors of NENs. The miR-224/PCSK9/GC axis binds to tumorigenesis and prognosis of pancreatic NENs (p-NENs).

SUBMITTER: Bai J 

PROVIDER: S-EPMC5351680 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

A retrospective study of NENs and miR-224 promotes apoptosis of BON-1 cells by targeting PCSK9 inhibition.

Bai Jian'an J   Na He H   Hua Xiumei X   Wei Yaling Y   Ye Tian T   Zhang Yiqiang Y   Jian Guo G   Zeng Weiwen W   Yan Lijun L   Tang Qiyun Q  

Oncotarget 20170101 4


Neuroendocrine neoplasms (NENs) represent relatively rare tumors. The lack of diagnostic, therapeutic method and prognostic factors makes them a challenge to us. We retrospectively reviewed the data of 205 NENs patients among which 157 cases were followed-up. Proprotein convertase subtilisin/kexin 9 (PCSK9), a regulator of low density lipoprotein cholesterol (LDL-C), was confirmed as a target gene of microRNA-224. We found an increased incidence of NENs from 2012 to 2015. Women were usually diag  ...[more]

Similar Datasets

| S-EPMC5711823 | biostudies-literature
| S-EPMC5023165 | biostudies-literature
| S-EPMC4102932 | biostudies-literature
| S-EPMC10428548 | biostudies-literature
| S-EPMC5386375 | biostudies-literature
| S-EPMC6365368 | biostudies-literature
| S-EPMC5945587 | biostudies-literature
| S-EPMC8097164 | biostudies-literature
| S-EPMC7585582 | biostudies-literature
| S-EPMC6984803 | biostudies-literature